by Stacey Johnson | Dec 27, 2019
If 2019 has felt like another year of information overload, it’s probably safe to assume you’ve missed some posts this year. Don’t despair! According to our readers, these were the posts with the most, the bee’s knees and the lollapalooza of...
by Stacey Johnson | Dec 20, 2019
Are you a risk taker? Do you pride yourself on giving unique and intriguing gifts? Well if you haven’t yet heard of Two Blind Brothers, pay attention. Two Blind Brothers produces clothing to fund blindness research at Foundation Fighting Blindness (FFB). As far as...
by Tara Fernandez | Oct 24, 2019
In a dark corner of the nucleus, a mutation lurks, up to no good. It stealthily swaps a DNA base – an A to a T – gleefully awaiting the catastrophic consequences on the encoded protein. A brave CRISPR molecule enters the nucleus and armed with its...
by CCRM Australia | Oct 10, 2019
Dr. Chih Wei Teng is Chief Operating Officer for CCRM Australia and wrote this blog with colleagues Alex Barrington and Dr. Emma Gallaher. To subscribe to the CCRM Australia newsletter: Click here Regenerative medicine is a risky business. The decades-long development...
by Stacey Johnson | Sep 6, 2019
The field of biotherapeutics – treatments produced by, or involving, living cells – is quickly evolving with the popularity and pursuit of new cell therapies. If you’re a student or young professional working in this space, you know this already. But how familiar are...
by Stacey Johnson | Aug 21, 2019
Cell and gene therapies are a game changer for patients. As academics and industry have been saying for years now, these therapies offer the promise of cures for previously incurable diseases and disorders. There were over 1,000 clinical trials underway worldwide at...
Comments